Cigna Corp (CI)
$158.41 0.30 (0.19%)
17:21 EDT CI Stock Quote Delayed 15 Minutes
Previous Close $158.41
Market Cap 38.54B
PE Ratio 15.55
Volume (Avg. Vol.) 1.47M
Day's Range 156.69 - 159.91
52-Week Range 141.95 - 226.60
Dividend & Yield 0.04 (0.03%)
CI Stock Predictions, Articles, and Cigna Corp News
- From InvestorPlace
- From the Web
This rally looks like it still has room to run, and top analysts think these 7 "strong buy" stocks can surge higher.
With the Medicare for All Act threatening to impart a radical paradigm shift, healthcare stocks are suddenly under heavy fire.
Walgreens stock tanked after the company reported weak second-quarter results and issued a light outlook, but there's opportunity here.
Cigna earnings for the fourth quarter of the year included poor 2019 guidance, sending CI stock falling on Friday.
Bears have emerged from hibernation. But not all stocks are suffering their wrath. Here are three healthcare stocks to buy.
With stocks trading at record levels, it can be difficult to identify the best stocks to buy now. Here are 10 picks that the experts have faith in.
Cigna stock will be boosted by the merger of Cigna and Express Scripts Holding Co. In the wake of the deal, CIT stock looks cheap.
Cigna is one step closer to a buyout of ESRX after approval from the Department of Justice. Here's what CI stock investors should expect.
Express Scripts (NASDAQ:ESRX), a pharmacy benefit management company operating in the United States and Canada, reported its latest earnings this past Wednesday, Aug. 1, and the stock moved sharply lower when the report crossed the tape.
The stock charts of CIGNA, Albemarle and Realty Income offer the best reliable technical reads here.
Citigroup recently reported earnings and it has since firmly planted a bullish reversal on its charts. This sets up bullish near-term trading opportunities in C stock.
If you’re looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GAR....
Amid an improving macro backdrop, we focus on five stocks with strong fundamentals from the insurance industry for better returns to investors. Compare Brokers....
CI stock is trading at over 20% below its yearly high, and it's discounted ahead of the Express Scripts deal. Investors will want to consider Cigna's long-term upside when the deal closes.
Cigna Corporation stock has had an ugly 2018 so far. And given the wait ahead of its Express Scripts acquisition, the Q1 earnings beat is unlikely to change the trend for CI stock.
Larry Robbins is a well-known GARP investor. Here are some of his hedge fund's -- Glenview Capital Management -- most undervalued stocks.
From The Street
From Market News Video
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!